Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 7/18/2012 2:04:47 PM : Underperform Start Price: $52.75 PCYC Score: +0.12

Nothing in Stage III, so a long wait at best !!

Report this Post Reply

Featured Broker Partners


Advertisement